AGENDA - Main Workshop DAY 2A - Wednesday Sep. 29, 2021: 4pm – 6pm

"Application of Multiple Technologies to Solve Complex Bioanalytical Issues"

Day 2A: Regeneron Antibody Cocktails Bioanalytical Challenges

Chair: Dr. Albert Torri, Vice President Bioanalytical Sciences, Head Preclin. Dev. and Protein Biochem., Regeneron
04:00pm–04:20pm: Dr. Michael Partridge, Associate Director Bioanalytical Sciences, Regeneron
"Bioanalytical Strategy for Development of Anti-Ebola Virus Monoclonal Antibody Cocktail"
04:20pm–04:40pm: Dr. Nisha Palackal, Director Protein Biochemistry, Regeneron
"Critical Reagents and Challenges in the Development of the Antibody Cocktail for SARS-CoV-2"
04:40pm–05:00pm: Dr. Giane Sumner, Senior Director Assay Development, Regeneron
"Bioanalytical Challenges in the Development of an Antibody Combination Therapy for SARS-CoV-2"
05:00pm–05:20pm: Mr. Matthew Andisik, Director Bioanalytical Operations, Regeneron
"Utilization of a Monoclonal Antibody Cocktail Therapy as Treatment for Patients with COVID-19: Clinical Bioanalysis Strategy and Pharmacokinetic & Immunogenicity Assessments"
05:20pm–05:40pm: Dr. Kristina McGuire, Senior Director, Head of CDx and Lab Operations, Regeneron
"Lessons Learned during SARS-COV-2 and Emergency Use Approval (EUA) for Diagnostic Tests"
05:40pm–06:00pm: Dr. Michael Partridge, Associate Director Bioanalytical Sciences, Regeneron
Dr. Nisha Palackal, Director Protein Biochemistry, Regeneron
Dr. Giane Sumner, Senior Director Assay Development, Regeneron
Mr. Matthew Andisik, Director Bioanalytical Operations, Regeneron
Dr. Kristina McGuire, Senior Director, Head of CDx and Lab Operations, Regeneron
"Panel Discussions on The Regeneron Antibody Cocktails Bioanalytical Challenges"




Agenda at a Glance Agenda at a Glance